NAUT (Nautilus Biotechnology Inc) Operating Margin

Public company logo of Nautilus Biotechnology Inc (NAUT)

Regarding operating margin metrics, this chart on GURU.Markets shows that -15105.70 serves as the current parameter value for Nautilus Biotechnology (NAUT). This trend reflects an eco-friendly approach to testing that reduces waste, alongside a dependency on the launch timeline of the proteomic platform while controlling R&D expenses. The development of DNA analysis through partnerships with centers accelerates the search for cancer targets, creating data synergy.

NAUT: Nautilus Biotechnology, Inc. Operating Sales Margin 07/04/2022 - 11/19/2026

Analytical breakdowns for Nautilus Biotechnology Inc (NAUT)

Fundamental company analysis:NAUT, Nautilus Bio
Core merchandise of Nautilus Biotechnology, Inc.

Negative dynamics in fundamental metrics highlight high risks, where the share of profit from core operations measures the efficiency of the operating cycle before taxes and interest. For Nautilus Biotechnology (NAUT), this indicator reflects the implementation stage of the Proteome Analysis Platform, as development costs exceed current revenues from pilot sales, making this chart a key tool for monitoring the company's speed in reaching operational break-even.

Key competitors

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Sangamo Therapeutics Inc. - Operating Margin|Operating Profit Rate MGX (Metagenomi, Inc)|DTIL: Operating Margin|GBIO: Operating Profit Ratio|Operating Profitability Boundless Bio Inc.|Operating Sales Margin Exicure (XCUR)|Operating Margin IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operating Profit Rate|Mustang Bio, Inc. - Operating Sales Margin|RNAZ - Operating Sales Margin|BNGO: Operating Sales Margin|APDN (Applied DNA Sciences Inc) - Return on Sales by Operating Profit|BLUE (Bluebird Bio) - Operating Sales Margin|ImmunoPrecise Antibodies Ltd - Operating Profit Rate|OMGA (Omega Therapeutics Inc) - Operating Margin|Operating Profitability OMIC|Operating Profitability Regulus Therapeutics Inc. (RGLS)|Operating Sales Margin Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Operating Sales Margin|Operating Profit Rate TCON|UBX - Operating Profitability